It was suggested that IGSF6 expression was increased in cancers such as bladder urothelial carcinoma (BLCA), esophageal carcinoma (ESCA), and glioblastoma multiforme (GBM), and was decreased in some others, particularly LUAD (Fig. 1A). The gene discussed is IGSF6; the disease is bladder transitional cell carcinoma.